Physician profile
Timothy M Snyder
NPI 1508828880
$849.97
in general payments reported to CMS, 2019-2025
13 companies · $138 in 2025
The $138 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2023: $239 · 2024: $228 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $264.17 | 2023-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $140.29 | 2023-2025 | Qelbree, Qelbree |
| Sanofi Pasteur INC. | $118.15 | 2019 | |
| Merck Sharp & Dohme LLC | $74.17 | 2019-2025 | Vaxelis, Gardasil 9, Rotateq |
| Cranial Technologies, INC | $53.77 | 2019-2024 | Doc Band |
| Astrazeneca Pharmaceuticals LP | $47.73 | 2023-2024 | Flumist Quadrivalent |
| Ironshore Pharmaceuticals INC. | $42.71 | 2019 | |
| Shire North American Group INC | $29.55 | 2019 | |
| Verrica Pharmaceuticals INC. | $22.13 | 2025 | Ycanth |
| Sobi, INC | $17.57 | 2023 | |
| Sanofi-Aventis U.S. LLC | $15.34 | 2024 | |
| Glaxosmithkline, LLC. | $12.64 | 2019 | |
| Dermira, INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.